Nateglinide, a new agent for postprandial glucose control in type 2 diabetes.
Kotapati
Srividya
S
Drug Information Center, Department of Pharmacy Services, Hartford Hospital, USA.
D001786:Blood Glucose / Q000187:drug effects; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000494:pharmacology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004347:Drug Interactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D000077715:Nateglinide; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology*
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D000077715:Nateglinide; D010649:Phenylalanine